Marcos André Costa

Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEYNOTE-042): a randomised, open-label, controlled, phase 3 trial

Jianying Zhou, Erdem Goker, Jun Zhao, 2019, The Lancet.

Impact of cranial stereotactic radiotherapy associated with immunotherapy with nivolumab and ipilimumab on overall survival in patients with melanoma brain metastases: a real-world evidence

Marcos André Costa, G. Gondim, D. G. de Castro, 2022, Clinical and Translational Oncology.

Safety and efficacy of modified dose-attenuated FOLFIRINOX chemotherapy in patients over 65 years with advanced pancreatic adenocarcinoma.

Marcos André Costa, M. Cruz, Carina Meira Abrahão, 2013 .

Lung Cancer and Isolated Adrenal Metastases: Different Disease?

Marcos André Costa, R. Younes, Rodrigo A S Sardenberg, 2019, Journal of Respiratory Diseases.

Mutation profile in non-small cell lung cancer: Analysis of a Brazilian population.

A. Buzaid, F. Schutz, Marcos André Costa, 2015 .